Being an outlier: a company non-prosperity sign?

Por Lucia Svabova, Marek Durica
Publicado em 2019-06-01

License Compliance Issues For Biopharmaceuticals: Special Challenges For Negotiations Between Companies And Non-Profit Research Institutions

Por Ponzio, Todd A., Feindt, Hans, Ferguson, Steven
Publicado em 2011

Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer

Por Nishio, Makoto, Hida, Toyoaki, Atagi, Shinji, Sakai, Hiroshi, Nakagawa, Kazuhiko, Takahashi, Toshiaki, Nogami, Naoyuki, Saka, Hideo, Takenoyama, Mitsuhiro, Maemondo, Makoto, Ohe, Yuichiro, Nokihara, Hiroshi, Hirashima, Tomonori, Tanaka, Hiroshi, Fujita, Shiro, Takeda, Koji, Goto, Koichi, Satouchi, Miyako, Isobe, Hiroshi, Minato, Koichi, Sumiyoshi, Naoki, Tamura, Tomohide
Publicado no ESMO Open (2017)

Introduction to the generalized theory of non-equilibrium Cahn-Hilliard phase transitions (Thermodynamic problems in continuum mechanics)

Por Evgeniy A Lukashev, Evgeniy V Radkevich, Nikolay N Yakovlev, Ol’ga A Vasil’eva
Publicado em 2017-09-01

AZD9291 in TKI EGFR resistance in non-small cell lung cancer and the new concept of phase I trials

Por Gil-Bazo, Ignacio, Rolfo, Christian
Publicado no Transl Lung Cancer Res (2016)

Comparative outcomes of squamous and non-squamous non-small cell lung cancer (NSCLC) patients...

Por McKeage, Mark J, Jameson, Michael B
Publicado em 2010

Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials

Por van den Bogert, Cornelis A., Souverein, Patrick C., Brekelmans, Cecile T. M., Janssen, Susan W. J., Koëter, Gerard H., Leufkens, Hubert G. M., Bouter, Lex M.
Publicado no PLoS One (2016)

Acute phase response to Mycoplasma haemofelis and ‘Candidatus Mycoplasma haemominutum’ infection in FIV-infected and non-FIV-infected cats

Por Korman, R.M., Cerón, J.J., Knowles, T.G., Barker, E.N., Eckersall, P.D., Tasker, S.
Publicado em 2012

Is overall survival still the primary endpoint in maintenance non-small cell lung cancer studies? An analysis of phase III randomised trials

Por Petrelli, Fausto, Barni, Sandro
Publicado no Transl Lung Cancer Res (2013)

Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity

Por Feng Liu, Stephen J. Walters, Steven A. Julious
Publicado em 2017-10-01

A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer

Por Zhao, Jun, Zhuo, Minglei, Wang, Zhijie, Duan, Jianchun, Wang, Yuyan, Wang, Shuhang, An, Tongtong, Wu, Meina, Wang, Jie
Publicado no Chin J Cancer Res (2016)

Design considerations and analysis planning of a phase 2a proof of concept study in rheumatoid arthritis in the presence of possible non-monotonicity

Por Liu, Feng, Walters, Stephen J., Julious, Steven A.
Publicado no BMC Med Res Methodol (2017)

A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer

Por Dragnev, Konstantin H., Whyman, Jeremy D., Hahn, Cynthia K., Kebbekus, Peter E., Kokko, Sarah F., Bhatt, Sunil M., Rigas, James R.
Publicado no J Thorac Dis (2018)

Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma

Por Gui, Lin, Han, Xiaohong, He, Xiaohui, Song, Yuanyuan, Yao, Jiarui, Yang, Jianliang, Liu, Peng, Qin, Yan, Zhang, Shuxiang, Zhang, Weijing, Gai, Wenlin, Xie, Liangzhi, Shi, Yuankai
Publicado no Chin J Cancer Res (2016)

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

Por Heyderman, Robert S, Madhi, Shabir A, French, Neil, Cutland, Clare, Ngwira, Bagrey, Kayambo, Doris, Mboizi, Robert, Koen, Anthonet, Jose, Lisa, Olugbosi, Morounfolu, Wittke, Frederik, Slobod, Karen, Dull, Peter M
Publicado no Lancet Infect Dis (2016)

Implementation of a Lean Manufacturing and SLP- based system for a footwear company

Por Sergio Enrique Munive Silvestre, Victor David Paucar Chaicha, Jose Carlos Alvarez Merino, S. Nallusamy
Publicado em 2022-05-01

Implementation of a Lean Manufacturing and SLP- based system for a footwear company

Por Sergio Enrique Munive Silvestre, Victor David Paucar Chaicha, Jose Carlos Alvarez Merino, S. Nallusamy
Publicado no Production (2022)

EURTAC first-line phase III randomized study in advanced non-small cell lung cancer: Erlotinib works also in European population

Por Gridelli, Cesare, Rossi, Antonio
Publicado em 2012

Reproducibility and non-redundancy of radiomic features extracted from arterial phase CT scans...

Por Qiu, Qingtao, Duan, Jinghao, Duan, Zuyun, Meng, Xiangjuan, Ma, Changsheng, Zhu, Jian, Lu, Jie, Liu, Tonghai, Yin, Yong
Publicado no Quant Imaging Med Surg (2019)

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous...

Por Yoshida, Kazushi, Yamada, Yasuhide
Publicado no Transl Lung Cancer Res (2015)